Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
14.89%
Operating Margin
99.62%
Net Margin
99.61%
Efficiency Metrics
Revenue per Expense Ratio
1.00
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
99.62%
Income Tax Rate
0.00%
EPS
8.6300000000
Balance Sheet Analysis
Current Ratio
0.00
Cash Ratio
0.85
Working Capital
$-7.93M
Debt to Equity
0.01
Debt to Assets
0.52%
Equity Ratio
97.96%
Cash Flow Analysis
Operating Cash Flow Ratio
-11.79%
Free Cash Flow Ratio
-11.79%
CapEx to Revenue
0.00%
Dividends Paid
$96.62M
Stock Buybacks
No buybacks
Total Shareholder Returns
$96.62M
Cash Position Change
407.58%
Key Takeaways (2023 FY)
Maintained positive net income growth despite revenue changes
Detailed Growth Metrics
Core Performance
Revenue
424.16%
Net Income
144.31%
EPS
142.53%
Operating Income
144.32%
Operational Efficiency
R&D Expenses
0.00%
SG&A Expenses
-24.31%
Operating Cash Flow
-177.58%
Free Cash Flow
-177.58%
Balance Sheet Health
Assets
26.10%
Debt
7,129.43%
Book Value per Share
19.54%
Inventory
0.00%
Shareholder Returns
Dividends per Share
-5.05%
Shares Outstanding
4.18%
Long Term Trends
3Y Revenue/Share
1,470.19%
5Y Revenue/Share
159.47%
3Y Dividend/Share
57.46%
5Y Dividend/Share
-8.41%